GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » ROA %

ZYUS Life Sciences (TSXV:ZYUS) ROA % : -172.64% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. ZYUS Life Sciences's annualized Net Income for the quarter that ended in Dec. 2023 was C$-97.94 Mil. ZYUS Life Sciences's average Total Assets over the quarter that ended in Dec. 2023 was C$56.73 Mil. Therefore, ZYUS Life Sciences's annualized ROA % for the quarter that ended in Dec. 2023 was -172.64%.

The historical rank and industry rank for ZYUS Life Sciences's ROA % or its related term are showing as below:

TSXV:ZYUS' s ROA % Range Over the Past 10 Years
Min: -80.1   Med: -59.1   Max: -38.1
Current: -70.15

During the past 3 years, ZYUS Life Sciences's highest ROA % was -38.10%. The lowest was -80.10%. And the median was -59.10%.

TSXV:ZYUS's ROA % is ranked worse than
89.56% of 1082 companies
in the Drug Manufacturers industry
Industry Median: 1.65 vs TSXV:ZYUS: -70.15

ZYUS Life Sciences ROA % Historical Data

The historical data trend for ZYUS Life Sciences's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences ROA % Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
ROA %
- -38.10 -80.10

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only -37.05 -28.99 -66.09 -22.02 -172.64

Competitive Comparison of ZYUS Life Sciences's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZYUS Life Sciences's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's ROA % distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's ROA % falls into.



ZYUS Life Sciences ROA % Calculation

ZYUS Life Sciences's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-42.591/( (64.712+41.627)/ 2 )
=-42.591/53.1695
=-80.10 %

ZYUS Life Sciences's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-97.94/( (71.833+41.627)/ 2 )
=-97.94/56.73
=-172.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


ZYUS Life Sciences  (TSXV:ZYUS) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-97.94/56.73
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-97.94 / 0.388)*(0.388 / 56.73)
=Net Margin %*Asset Turnover
=-25242.27 %*0.0068
=-172.64 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


ZYUS Life Sciences ROA % Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


ZYUS Life Sciences (TSXV:ZYUS) Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines